|
Legacy Pharmaceuticals International currently sells finished pharmaceutical products to more than 70 countries globally. We serve the following regions either directly or through distribution partners and its customers:
- EU/ Eastern Europe
- Middle East
- Americas
- Asia Pacific including China and Japan
- Africa
- Australasia/Oceania
Marketing and sales activities are handled in Birsfelden where our Customer Service Department interacts on a daily basis with customers world-wide. Legacy has selected partners throughout the world which have their own sales forces, regulatory affairs and/or distribution channels.
Key Legacy staff have been working at the site for over 20 years and have experience with over 70 countries worldwide. This includes most countries in all major regions of the world:
1. Europe - EU - Non-EU
2. Asia - CIS and Mongolia - Southeast - Middle East
3. Americas - U.S. and Canada - Caribbean - Central - South
4. Africa
5. Oceania
Legacy meets the needs of customers and partners operating the world over. Legacy is able to supply the right documentation on time for regulatory affairs (registration and ongoing), order handling, shipping and payment for the goods.
Legacy's Swiss operations handle regulatory affairs in two ways for Legacy's Swiss operations. Within Switzerland we work with competent external agencies that carry out the necessary liaison between our factory or third party suppliers and our customers and partners. In other markets, Legacy has chosen partners who are familiar with the local regulatory needs and which deal on a day to day basis with the local regulatory authorities. Legacy's US operations work with an external agency for drug regulatory and CMC updates.
Legacy's manufacturing sites have been inspected and/or are approved by the following agencies:
-
Swissmedic (production, import, export & distribution of pharmaceuticals including narcotics)
-
Saudi Arabian Health Authorities
-
The European Drugs Agency
-
Ministry of Health, Labor and Welfare (Japan)
-
The State Food and Drug Administration of the Peoples Republic of China
-
The Taiwan International Health Action
-
ILSI Argentina
-
World Health Organisation
|